High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$388K
$388,450
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| GALT |
GALECTIN THERAPEUTICS INC
|
CEO
Equity Compensation
|
2025-12-17 | $22,391x2 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CEO
10b5-1 Sell
|
2025-12-17 | $55,241 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CEO
Other
|
2025-11-18 | $16,211 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CEO
10b5-1 Sell
|
2025-11-18 | $41,723 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CEO
Other
|
2025-11-17 | $37,475 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CEO
10b5-1 Sell
|
2025-11-17 | $94,643 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CEO
Other
|
2025-11-10 | $4,462 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CEO
10b5-1 Sell
|
2025-11-10 | $11,252 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CEO
Other
|
2025-11-05 | $478 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CEO
10b5-1 Sell
|
2025-11-05 | $1,200 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CEO
Other
|
2025-11-04 | $34,464 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CEO
10b5-1 Sell
|
2025-11-04 | $87,529 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CEO
Other
|
2025-11-03 | $3,107 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CEO
10b5-1 Sell
|
2025-11-03 | $7,813 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CEO
Other
|
2025-09-12 | $33,460 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CEO
10b5-1 Sell
|
2025-09-12 | $89,048 | S | Form 4 |